- Home
- PODD vs XP Comparison
PODD vs XP Comparison
Compare PODD & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PODD | XP |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.2B |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PODD | XP |
|---|---|---|
| Price | $136.19 | $20.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 6 |
| Target Price | ★ $341.48 | $23.17 |
| AVG Volume (30 Days) | 1.6M | ★ 7.0M |
| Earning Date | 05-06-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.67 | N/A |
| Revenue | ★ $2,708,100,000.00 | N/A |
| Revenue This Year | $24.55 | $19.00 |
| Revenue Next Year | $19.18 | $13.64 |
| P/E Ratio | $50.85 | ★ $11.42 |
| Revenue Growth | ★ 30.73 | N/A |
| 52 Week Low | $126.40 | $14.80 |
| 52 Week High | $354.88 | $23.13 |
Technical Indicators
Market Signals| Indicator | PODD | XP |
|---|---|---|
| Relative Strength Index (RSI) | 40.23 | 63.80 |
| Support Level | $131.24 | $18.57 |
| Resistance Level | $143.45 | $21.79 |
| Average True Range (ATR) | 4.61 | 0.72 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 32.23 | 63.85 |
Price Performance
Historical ComparisonAbout PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission. Geographically, the company derives maximum revenue from Brazil and also has its presence in other countries.